SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-059207
Filing Date
2020-11-18
Accepted
2020-11-18 18:19:15
Documents
2
Period of Report
2020-11-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6187
2 POA DOCUMENT poa.txt EX-24.3_945886 3559
  Complete submission text file 0001209191-20-059207.txt   11128
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Issuer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O OLEMA PHARMACEUTICALS, INC. 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address
Harmon Cyrus (Reporting) CIK: 0001831410 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39712 | Film No.: 201326238